Millie Figueroa was born with type 1 SMA and in the past, most children with this condition died before their second birthdays. In Millie’s case, though, she received gene therapy when she was 19 days old along with additional ongoing treatments. Today, at age 3, she is thriving. For SMA, early intervention is key. This is what gives children a fighting chance to prevent the symptoms of SMA.
- The Good Complex News
- •